## Distinguishing NMJ from Central Synapses ### Structural and Functional Comparison | Feature | NMJ | Central Synapse | |---------|-----|----------------| | **Presynaptic-Postsynaptic Ratio** | 1:1 (one motor neuron terminal per muscle fiber) | Many-to-one (convergence) or one-to-many (divergence) | | **Safety Factor** | Very high (~200–300 mV margin) | Low (~1–2 mV margin) | | **Neurotransmitter** | Acetylcholine only | Multiple (glutamate, GABA, dopamine, etc.) | | **Postsynaptic Mechanism** | Direct ionotropic (nicotinic ACh receptors) | Ionotropic AND metabotropic (G-protein coupled) | | **Synaptic Cleft** | Wide (~50 nm), specialized | Narrow (~20 nm) | | **Acetylcholinesterase** | High concentration in basal lamina | Absent or minimal | **Key Point:** The NMJ is a **highly specialized, reliable, one-to-one transmission system** with an enormous safety margin. This ensures every action potential in the motor neuron reliably triggers muscle contraction. Central synapses, by contrast, integrate multiple weak inputs and require temporal/spatial summation. ### Why This Matters Clinically **Clinical Pearl:** The high safety factor at the NMJ explains why myasthenia gravis (antibodies against nicotinic receptors) causes muscle weakness only when ~70–80% of receptors are blocked—the system has redundancy. At central synapses, loss of even a few receptors can cause profound dysfunction. **High-Yield:** The **one-to-one, high-safety-factor architecture** is the single best discriminator. It reflects the NMJ's role as a reliable motor command transducer, not an integrator. [cite:Guyton and Hall Textbook of Medical Physiology Ch 7]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.